Experimental Bone Marrow Transplant Protocol

NCT00061581 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

NIH

Sponsor class

Conditions

Acute Lymphocytic Leukemia
Chronic Myeloid Leukemia
Acute Myelocytic Leukemia
Myelodysplastic Syndromes
Myeloproliferative Disorders

Interventions

DEVICE: Isolex 300i Stem Cell Selection

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)